PHYBOT

PHYBOT (动易科技) is a Beijing-based developer of full-size electric humanoid robots, founded in 2024. The company operates from China's capital and has disclosed two platforms: the PHYBOT C1 humanoid and the PHYBOT M1, both described as bipedal systems targeting general-purpose applications. PHYBOT's formation sits within a broader wave of Chinese humanoid startups that launched during 2023–2024, a period that saw increased venture interest in general-purpose robotics across several Chinese cities. The company maintains a bilingual web presence, though publicly available detail on hardware specifications, software architecture, and autonomy capabilities remains thin. The company's brief operating history and the early stage of its disclosed platforms place PHYBOT among the newer entrants in an increasingly crowded field. No public information confirms manufacturing scale, pilot agreements, or commercial availability as of mid-2026.

PHYBOT has disclosed two humanoid robot platforms. The PHYBOT C1 is designated as a humanoid robot, while the PHYBOT M1 is listed as a full-size electric humanoid. Both are described as bipedal systems, but the company has not released detailed specifications distinguishing the two models in terms of payload, degrees of freedom, onboard compute, runtime, or intended use cases. The naming convention — C1 and M1 — suggests a possible product line segmentation, though the company has not explained what differentiates the two platforms. Without published spec sheets or demonstration footage showing operational capabilities, the maturity of either model is difficult to assess from public materials alone. In the context of the broader humanoid market, a two-model portfolio at this stage is not unusual for an early-stage developer. Several Chinese and North American startups have disclosed similar platform counts during their first two years. The practical significance of the portfolio will depend on whether PHYBOT can demonstrate working hardware, provide pricing, and articulate clear application targets for each model.

PHYBOT's deployment relevance remains contingent on factors not yet publicly confirmed. The company has disclosed two humanoid platforms but has not published evidence of customer pilots, field trials, or commercial agreements. No operating metrics — such as runtime, task completion rates, or uptime data — are available in the public domain. Manufacturing partnerships, pricing, and service-and-support infrastructure have also not been detailed. The company's 2024 founding date makes it a relatively recent entrant, and the gap between platform disclosure and verifiable deployment can be substantial for hardware startups in general-purpose robotics. Buyers and integrators evaluating the vendor will likely require evidence of working prototypes, technical specifications sufficient for site planning, and clarity on the commercial terms under which the robots would be made available. For organizations tracking deployment intelligence, PHYBOT represents an early-stage developer whose practical relevance will be shaped by whether it transitions from platform disclosure to customer-confirmed pilots and operating data over the next 12 to 24 months. Without those milestones, the vendor's current deployment footprint is effectively unconfirmed.